Federal Reserve's December OutlookDezhe Medicine is a listed company in science and technology innovation board, and it is an innovation-driven biomedical company with global competitiveness. Therefore, its refinancing has been approved by the Shanghai Stock Exchange, which also shows that the supervision is tolerant of companies with core technology and hard power. Although it may not be ideal financially for the time being, it has broad prospects and great imagination, which is worthy of support.The latest progress of stamp duty in Hong Kong has come!
Statement: Personal opinion, for reference only!Dizhe Pharmaceutical announced that the company's private placement plan has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of the unprofitable enterprise on the Shanghai Stock Exchange has been approved since the release of "Keba Article".Quantum technology is one of the important directions of the next industrial revolution, and it is also one of the concepts that we have always suggested that everyone pay attention to. At present, it is in the initial stage, and the imagination space is huge. You can dig it well.
Federal Reserve's December OutlookA major breakthrough! Quantum technology frenzy strikesIf we can continue to cut interest rates in December, it will undoubtedly be a big plus for A shares, and the pressure on the exchange rate will be further reduced, which may become a turning point in the short term.
Strategy guide
Strategy guide 12-14